Chemoinformaics analysis of 6-O-Galloylglucose
| Molecular Weight | 332.261 | nRot | 7 |
| Heavy Atom Molecular Weight | 316.133 | nRig | 8 |
| Exact Molecular Weight | 332.074 | nRing | 1 |
| Solubility: LogS | -0.922 | nHRing | 0 |
| Solubility: LogP | -1.294 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 1 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 10 | No. of Arom Bond | 6 |
| nHA | 10 | APOL | 40.3987 |
| nHD | 7 | BPOL | 19.5233 |
| QED | 0.21 |
| Synth | 3.562 |
| Natural Product Likeliness | 1.046 |
| NR-PPAR-gamma | 0.061 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.812 |
| HIA | 0.74 |
| CACO-2 | -6.252 |
| MDCK | 0.000325745 |
| BBB | 0.796 |
| PPB | 0.559056 |
| VDSS | 0.691 |
| FU | 0.498411 |
| CYP1A2-inh | 0.053 |
| CYP1A2-sub | 0.024 |
| CYP2c19-inh | 0.009 |
| CYP2c19-sub | 0.045 |
| CYP2c9-inh | 0.003 |
| CYP2c9-sub | 0.154 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.129 |
| CYP3a4-inh | 0.007 |
| CYP3a4-sub | 0.007 |
| CL | 8.221 |
| T12 | 0.967 |
| hERG | 0.187 |
| Ames | 0.077 |
| ROA | 0.003 |
| SkinSen | 0.131 |
| Carcinogencity | 0.008 |
| EI | 0.022 |
| Respiratory | 0.035 |
| NR-Aromatase | 0.009 |
| Antiviral | Yes |
| Prediction | 0.707926 |